MaxCyte
MaxCyte is a leader in cell transfection and modification platforms, bringing to market its patented flow electroporation technology for use in the discovery and development of small molecule drugs, biotherapeutics and innovative cellular therapeutics. MaxCyte’s proprietary flow technology uniquely fulfills the needs for high quality, fully scalable cell modification.
The MaxCyte® STX™ Scalable Transfection System was designed for the rapid development and consistent production of (co)transfected primary cells, stem cells, and cell lines for cell-based screening assays for ion channels, GPCRs, and other targets, with superior performance and flexibility with Seamless Scalability™ from the bench to HTS scale.
The MaxCyte technology has been proven through over a decade of use in the clinical applications, inlcuidng a Master File designation with the CBER Division of the U.S. FDA and clearance by NIH's RAC and Health Canada. The MaxCyte system can be used to develop cell therapeutics for a variety of diseases and can be used to load cells for both autologous and allogeneic therapies.
Reviews
- Ease of use
- After sales service
- Value for money
"This system is very easy to use, a new operator can be trained in minutes. It is fast, transfections can be completed in seconds. Very versatile- it ..."
Paul Sharpe
‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.| Status: | No. Reviews Published: |
| Member | 0 |
Reviewer | 1-4 |
| Advanced Reviewer | 5-14 |
| Expert Reviewer | 15+ |
To be seen as an authority on SelectScience, find your products to review today., AstraZeneca
Latest Videos
Latest news
News
Rapid Antibody and Protein Production using the MaxCyte® STX™ Transfection System
09 Sep 2011
-
MaxCyte Showcases Innovations in High-Throughput Transfection for Cell-based Assays & Difficult-to-Transfect Cells
30 Aug 2011
-
MaxCyte® STX™ Scalable Transfection System Simplifies Protein and Antibody Production
27 May 2011
-
MaxCyte Highlights Innovations in High-throughput Transfection for Cell-based Assays & Protein Production
21 Mar 2011
-
Expression of Functional Ion Channels Using the MaxCyte STX Demonstrated in Automated Electrophysiology Assays
09 Mar 2011
Application articles
-
Increased Laboratory Productivity for CHO Cell Antibody Production Using Scalable Transient Gene Expression
MaxCyte16 Nov 2012
-
Development of Fully Scalable Reporter Gene Assays for Studying Transcriptional Regulation and Receptor Activation using Flow Electroporation
MaxCyte16 Nov 2012
-
Primary Cell and Stem Cell-based Assays Enabled using MaxCyte Transient Transfection System
MaxCyte31 Oct 2011
-
Rapid Development of a High Titer Protein Production Method with CHO Cells Transiently Transfected using MaxCyte Electroporation Technology
MaxCyte26 May 2011
-
High Throughput Transfection of Stem Cells, Primary Cells and Difficult-to-Transfect Cell Lines: Jurkat, CHO, Human Skeletal Muscle Cells & Primary Neuronal Cell Transfection using a Scalable, Electroporation-Based Technology.
MaxCyte28 Mar 2011
